1,887
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparative effects of the antioxidant glutathione with metformin and Diane-35 on hormonal, metabolic, and inflammatory indicators in a DHEA-induced PCOS rat model

, ORCID Icon, , , , , & show all
Article: 2302086 | Received 27 Oct 2023, Accepted 02 Jan 2024, Published online: 22 Jan 2024

References

  • Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:1. doi:10.1038/NRDP.2016.57.
  • Fauser BCJM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–8. doi:10.1016/j.fertnstert.2003.10.004.
  • Dludla PV, Mazibuko-Mbeje SE, Nyambuya TM, et al. The beneficial effects of N-acetyl cysteine (NAC) against obesity associated complications: a systematic review of pre-clinical studies. Pharmacol Res. 2019;146:104332. doi:10.1016/J.PHRS.2019.104332.
  • Howkins J, Bourne G. Chapter 32 disorders of the ovary. In: Padubidri VG, Daftary SN, editors. Shaw’s textb gynecol. 16th ed. New Delhi: elsevier India Private Limited; 2014. p. 429–434.
  • Vink JM, Sadrzadeh S, Lambalk CB, et al. Heritability of polycystic ovary syndrome in a dutch twin-family study. J Clin Endocrinol Metab. 2006;91(6):2100–2104. doi:10.1210/jc.2005-1494.
  • Azziz R, Marin C, Hoq L, et al. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005;90(8):4650–4658. doi:10.1210/JC.2005-0628.
  • Sabuncu T, Vural H, Harma M, et al. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001;34(5):407–413. doi:10.1016/S0009-9120(01)00245-4.
  • Verit FF, Erel O. Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters. Gynecol Obstet Invest. 2008;65(4):233–239. doi:10.1159/000113046.
  • Qu X, Donnelly R. Sex hormone-Binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome. Int J Mol Sci. 2020;21(21):1–17. doi:10.3390/IJMS21218191.
  • Nur Torun A, Vural M, Cece H, et al. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered. Gynecol Endocrinol. 2011;27(12):988–992. doi:10.3109/09513590.2011.569798.
  • Soltani M, Moghimian M, Abtahi-Evari SH, et al. The effects of clove oil on The biochemical and HistologicalParameters, and autophagy markers in polycystic OvarySyndrome-model rats. Int J Fertil Steril. 2023;17(3):187–194. doi:10.22074/IJFS.2022.543640.1260.
  • Kelly CCJ, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453–2455. doi:10.1210/JCEM.86.6.7580.
  • Lu J, Wang Z, Cao J, et al. A novel and compact review on the role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2018;16(1):80. doi:10.1186/S12958-018-0391-5.
  • Feng W, Jia YY, Zhang DY, et al. Management of polycystic ovarian syndrome with diane-35 or diane-35 plus metformin. Gynecol Endocrinol. 2016;32(2):147–150. doi:10.3109/09513590.2015.1101441.
  • Kuşçu NK, Var A. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2009;88(5):612–617. doi:10.1080/00016340902859315.
  • Hammond CL, Lee TK, Ballatori N. Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. J Hepatol. 2001;34(6):946–954. doi:10.1016/S0168-8278(01)00037-X.
  • Osuka S, Nakanishi N, Murase T, et al. Animal models of polycystic ovary syndrome: a review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides. Reprod Med Biol. 2019;18(2):151–160. doi:10.1002/RMB2.12262.
  • Motta AB. Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2010;119(3-5):105–111. doi:10.1016/J.JSBMB.2010.02.015.
  • Furat Rencber S, Kurnaz Ozbek S, Eraldemlr C, et al. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. J Ovarian Res. 2018;11(1):55. doi:10.1186/S13048-018-0427-7.
  • Pedersen T, Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil. 1968;17(3):555–557. doi:10.1530/JRF.0.0170555.
  • Tumu VR, Govatati S, Guruvaiah P, et al. An interleukin-6 gene promoter polymorphism is associated with polycystic ovary syndrome in South ındian women. J Assist Reprod Genet. 2013;30(12):1541–1546. doi:10.1007/S10815-013-0111-1.
  • Xu X, Du C, Zheng Q, et al. Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review. BMC Womens Health. 2014;14:93. doi:10.1186/1472-6874-14-93.
  • Lin YS, Tsai SJ, Lin MW, et al. Interleukin-6 as an early chronic inflammatory marker in polycystic ovary syndrome with insulin receptor substrate-2 polymorphism. Am J Reprod Immunol. 2011;66(6):527–533. doi:10.1111/J.1600-0897.2011.01059.X.
  • Wang J, Zhu L, Hu K, et al. Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis: a PRISMA-compliant article. Medicine. 2017;96(39):e8183. doi:10.1097/MD.0000000000008183.
  • Mishra AK, Dingli D. Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells. Leukemia. 2019;33(11):2695–2709. doi:10.1038/S41375-019-0470-4.
  • Wrotek S, Domagalski K, Jędrzejewski T, et al. Buthionine sulfoximine, a glutathione depletor, attenuates endotoxic fever and reduces IL-1β and IL-6 level in rats. Cytokine. 2017;90:31–37. doi:10.1016/J.CYTO.2016.10.005.
  • Kil IS, Kim SY, Park JW. Glutathionylation regulates IkappaB. Biochem Biophys Res Commun. 2008;373(1):169–173. doi:10.1016/J.BBRC.2008.06.007.
  • Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994;12(1):141–179. doi:10.1146/ANNUREV.IY.12.040194.001041.
  • Rudnicka E, Suchta K, Grymowicz M, et al. Chronic low grade ınflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):789. doi:10.3390/IJMS22073789.
  • Duan X, Zhou M, Zhou G, et al. Effect of metformin on adiponectin in PCOS: a meta-analysis and a systematic review. Eur J Obstet Gynecol Reprod Biol. 2021;267:61–67. doi:10.1016/J.EJOGRB.2021.10.022.
  • Wu G, Hu X, Ding J, et al. The effect of glutamine on dehydroepiandrosterone-induced polycystic ovary syndrome rats. J Ovarian Res. 2020;13(1):57. doi:10.1186/S13048-020-00650-7.
  • Raygan F, Behnejad M, Ostadmohammadi V, et al. Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2018;120(1):33–40. doi:10.1017/S0007114518001253.
  • Razavi M, Jamilian M, Kashan ZF, et al. Selenium supplementation and the effects on reproductive outcomes, biomarkers of ınflammation, and oxidative stress in women with polycystic ovary syndrome. Horm Metab Res. 2016;48(3):185–190. doi:10.1055/S-0035-1559604.
  • Askari M, Faryabi R, Mozaffari H, et al. The effects of N-Acetylcysteine on serum level of inflammatory biomarkers in adults. Findings from a systematic review and meta-analysis of randomized clinical trials. Cytokine. 2020;135:155239. doi:10.1016/J.CYTO.2020.155239.
  • Khodaeifar F, Mohammad Bagher Fazljou S, Khaki A, et al. Investigating the role of hydroalcoholic extract of apium graveolens and cinnamon zeylanicum on metabolically change and ovarian oxidative ınjury in a rat model of polycystic ovary syndrome. Aras part med. International J Women’s Health Reproduct Sci. 2018;7(1):92–98. doi:10.15296/ijwhr.2019.15.
  • Nassif RM, Chalhoub E, Chedid P, et al. Metformin ınhibits ROS production by human M2 macrophages via the activation of AMPK. Biomedicines. 2022;10(2):319. doi:10.3390/BIOMEDICINES10020319.
  • Sulaiman MAH, Al-Farsi YM, Al-Khaduri MM, et al. Polycystic ovarian syndrome is linked to increased oxidative stress in omani women. Int J Womens Health. 2018;10:763–771. doi:10.2147/IJWH.S166461.
  • Mohammadi Z, Hosseinianvari S, Ghazalian N, et al. The ımpact of chrysin on The folliculogenesis and ovarian apoptosis in Ischemia-Reperfusion ınjury in The rat model. Int J Fertil Steril [Internet]. 2022;16:299–305. doi:10.22074/IJFS.2021.540364.1200.
  • Roshanaee MK, Abtahi-Eivary SH, Shokoohi M, et al. Protective effect of minocycline on bax and bcl-2 gene expression, histological damages and oxidative stress ınduced by ovarian torsion in adult rats. Int J Fertil Steril. 2022;16(1):30–35. doi:10.22074/IJFS.2021.522550.1069.
  • Shokoohi M, Soltani M, Abtahi-Eivary SH, et al. Effect of hydro-alcoholic extract of Olea europaea on apoptosis-related genes and oxidative stress in a rat model of torsion/detorsion-induced ovarian damage. Asian Pac J Reprod. 2019;8(4):148–156. doi:10.4103/2305-0500.262831.
  • Abdallah ABE, El-Ghannam MA, Hasan AA, et al. Selenium nanoparticles modulate Steroidogenesis-Related genes and ımprove ovarian functions via regulating androgen receptors expression in polycystic ovary syndrome rat model. Biol Trace Elem Res. 2023;201(12):5721–5733. doi:10.1007/S12011-023-03616-0.
  • Sharma N, Lugani Y, Kaur A, Ahuja VK. Effect of metformin on insulin levels, blood sugar, and body mass index in polycystic ovarian syndrome cases. J Family Med Prim Care, 2019;8:2691, 2695. doi:10.4103/JFMPC.JFMPC_490_19.
  • Attia GR, Rainey WE, Carr BR. Metformin directly inhibits androgen production in human thecal cells. Fertil Steril. 2001;76(3):517–524. doi:10.1016/S0015-0282(01)01975-6.
  • Mansfield R, Galea R, Brincat M, et al. Metformin has direct effects on human ovarian steroidogenesis. Fertil Steril. 2003;79(4):956–962. doi:10.1016/S0015-0282(02)04925-7.
  • Søndergård SD, Cintin I, Kuhlman AB, et al. The effects of 3 weeks of oral glutathione supplementation on whole body insulin sensitivity in obese males with and without type 2 diabetes: a randomized trial. Appl Physiol Nutr Metab. 2021;46(9):1133–1142. doi:10.1139/APNM-2020-1099.
  • Xing C, Li C, He B. Insulin sensitizers for ımproving the endocrine and metabolic profile in overweight women With PCOS. J Clin Endocrinol Metab. 2020;105(9):2950–2963. doi:10.1210/CLINEM/DGAA337.
  • Xing C, Lv B, Zhao H, et al. Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats. J Steroid Biochem Mol Biol. 2021;214:105992. doi:10.1016/J.JSBMB.2021.105992.
  • Al-Nozha O, Habib F, Mojaddidi M, et al. Body weight reduction and metformin: roles in polycystic ovary syndrome. Pathophysiology. 2013;20(2):131–137. doi:10.1016/J.PATHOPHYS.2013.03.002.
  • Keevil BG, Adaway J. Assessment of free testosterone concentration. J Steroid Biochem Mol Biol. 2019;190:207–211. doi:10.1016/J.JSBMB.2019.04.008.
  • De Medeiros SF, Medeiros MD, Santos NDS, et al. Combined oral contraceptive effects on low-grade chronic ınflammatory mediators in women with polycystic ovary syndrome: a systematic review and meta-analysis. Int J Inflam. 2018;2018:9591509. doi:10.1155/2018/9591509.